166 related articles for article (PubMed ID: 33215327)
1. Unraveling neuroHIV in the Presence of Substance Use Disorders.
Lin Y; He JJ; Sorensen R; Chang L
J Neuroimmune Pharmacol; 2020 Dec; 15(4):578-583. PubMed ID: 33215327
[TBL] [Abstract][Full Text] [Related]
2. HIV Neuropathogenesis in the Presence of a Disrupted Dopamine System.
Nickoloff-Bybel EA; Calderon TM; Gaskill PJ; Berman JW
J Neuroimmune Pharmacol; 2020 Dec; 15(4):729-742. PubMed ID: 32506353
[TBL] [Abstract][Full Text] [Related]
3. Promoting Global Health - Prevention and Treatment of Substance Abuse and HIV in Asia.
Li MD; Hser YI; Chen Z; Chang L
J Neuroimmune Pharmacol; 2016 Sep; 11(3):379-82. PubMed ID: 27484319
[TBL] [Abstract][Full Text] [Related]
4. Editors' Commentary for Special Issue: The 2017 CALDAR Summer Institute and International Conference Promoting Global Health-Precision Research in Substance Abuse, HIV, and Care.
Chang L; Li MD; Hser YI
J Neuroimmune Pharmacol; 2018 Dec; 13(4):427-429. PubMed ID: 30382511
[TBL] [Abstract][Full Text] [Related]
5. NeuroAIDS, drug abuse, and inflammation: building collaborative research activities.
Berman JW; Carson MJ; Chang L; Cox BM; Fox HS; Gonzalez RG; Hanson GR; Hauser KF; Ho WZ; Hong JS; Major EO; Maragos WF; Masliah E; McArthur JC; Miller DB; Nath A; O'Callaghan JP; Persidsky Y; Power C; Rogers TJ; Royal W
J Neuroimmune Pharmacol; 2006 Dec; 1(4):351-99. PubMed ID: 18040811
[TBL] [Abstract][Full Text] [Related]
6. NeuroHIV and use of addictive substances.
Chang SL; Connaghan KP; Wei Y; Li MD
Int Rev Neurobiol; 2014; 118():403-40. PubMed ID: 25175871
[TBL] [Abstract][Full Text] [Related]
7. The 20th scientific conference of the Society on NeuroImmune Pharmacology.
Fox HS
J Neuroimmune Pharmacol; 2014 Mar; 9(1):1-2. PubMed ID: 24573530
[TBL] [Abstract][Full Text] [Related]
8. The HIV-1 transgenic rat model of neuroHIV.
Vigorito M; Connaghan KP; Chang SL
Brain Behav Immun; 2015 Aug; 48():336-49. PubMed ID: 25733103
[TBL] [Abstract][Full Text] [Related]
9. Animal models of HIV-associated disease of the central nervous system.
Mallard J; Williams KC
Handb Clin Neurol; 2018; 152():41-53. PubMed ID: 29604983
[TBL] [Abstract][Full Text] [Related]
10. HIV Infection and Neurocognitive Disorders in the Context of Chronic Drug Abuse: Evidence for Divergent Findings Dependent upon Prior Drug History.
Illenberger JM; Harrod SB; Mactutus CF; McLaurin KA; Kallianpur A; Booze RM
J Neuroimmune Pharmacol; 2020 Dec; 15(4):715-728. PubMed ID: 32533296
[TBL] [Abstract][Full Text] [Related]
11. Neuropathogenesis of human immunodeficiency virus infection.
Sillman B; Woldstad C; Mcmillan J; Gendelman HE
Handb Clin Neurol; 2018; 152():21-40. PubMed ID: 29604978
[TBL] [Abstract][Full Text] [Related]
12. NeuroAIDS in children.
Wilmshurst JM; Hammond CK; Donald K; Hoare J; Cohen K; Eley B
Handb Clin Neurol; 2018; 152():99-116. PubMed ID: 29604987
[TBL] [Abstract][Full Text] [Related]
13. Magnetic nanotherapeutics for dysregulated synaptic plasticity during neuroAIDS and drug abuse.
Sagar V; Atluri VS; Pilakka-Kanthikeel S; Nair M
Mol Brain; 2016 May; 9(1):57. PubMed ID: 27216740
[TBL] [Abstract][Full Text] [Related]
14. Modulatory Effects of Nicotine on neuroHIV/neuroAIDS.
Han H; Yang Z; Chang SL; Li MD
J Neuroimmune Pharmacol; 2018 Dec; 13(4):467-478. PubMed ID: 30215204
[TBL] [Abstract][Full Text] [Related]
15. CROI 2014: Neurologic complications of HIV infection.
Spudich SS
Top Antivir Med; 2014 May; 22(2):594-601. PubMed ID: 24901885
[TBL] [Abstract][Full Text] [Related]
16. Bidirectional Associations among Nicotine and Tobacco Smoke, NeuroHIV, and Antiretroviral Therapy.
Ghura S; Gross R; Jordan-Sciutto K; Dubroff J; Schnoll R; Collman RG; Ashare RL
J Neuroimmune Pharmacol; 2020 Dec; 15(4):694-714. PubMed ID: 31834620
[TBL] [Abstract][Full Text] [Related]
17. Global NeuroAIDS roundtable.
Joseph J; Achim CL; Boivin MJ; Brew BJ; Clifford DB; Colosi DA; Ellis RJ; Heaton RK; Gallo-Diop A; Grant I; Kanmogne GD; Kumar M; Letendre S; Marcotte TD; Nath A; Pardo CA; Paul RH; Pulliam L; Robertson K; Royal W; Sacktor N; Sithinamsuwan P; Smith DM; Valcour V; Wigdahl B; Wood C
J Neurovirol; 2013 Feb; 19(1):1-9. PubMed ID: 23354550
[TBL] [Abstract][Full Text] [Related]
18. Neuroimmunity, drugs of abuse, and neuroAIDS.
Burdo TH; Katner SN; Taffe MA; Fox HS
J Neuroimmune Pharmacol; 2006 Mar; 1(1):41-9. PubMed ID: 18040790
[TBL] [Abstract][Full Text] [Related]
19. The validity of the Substance Abuse and Mental Illness Symptom Screener (SAMISS) in people living with HIV/AIDS in primary HIV care in Cape Town, South Africa.
Breuer E; Stoloff K; Myer L; Seedat S; Stein DJ; Joska JA
AIDS Behav; 2014 Jun; 18(6):1133-41. PubMed ID: 24452497
[TBL] [Abstract][Full Text] [Related]
20. Advancing the preclinical study of comorbid neuroHIV and substance use disorders: Current perspectives and future directions.
Namba MD; Xie Q; Barker JM
Brain Behav Immun; 2023 Oct; 113():453-475. PubMed ID: 37567486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
